Last updated on April 2019

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey


Brief description of study

A multicenter, prospective cohort study of the mutation status of patients with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who are being treated with first or subsequent tyrosine kinase inhibitor (TKI) therapy in the UK, Ireland, or France.

Clinical Study Identifier: NCT03647215

Find a site near you

Start Over

Derriford Hospital

Plymouth, United Kingdom
  Connect »

Queen's Hospital

Romford, United Kingdom
  Connect »

Aberdeen Royal Infirmary

Aberdeen, United Kingdom
  Connect »

Queen Alexandra Hospital

Portsmouth, United Kingdom
  Connect »

Medway Maritime Hospital

Gillingham, United Kingdom
  Connect »

Blackpool Victoria Hospital

Blackpool, United Kingdom
  Connect »

Royal Oldham Hospital

Manchester, United Kingdom
  Connect »

Queens Medical Centre

Nottingham, United Kingdom
  Connect »

Ipswich Hospital

Ipswich, United Kingdom
  Connect »

Russells Hall Hospital

Dudley, United Kingdom
  Connect »

Bradford Royal Infirmary

Bradford, United Kingdom
  Connect »

Monklands Hospital

Airdrie, United Kingdom
  Connect »

Addenbrooke's Hospital

Cambridge, United Kingdom
  Connect »

Western General Hospital

Edinburgh, United Kingdom
  Connect »

Guy's Hospital

London, United Kingdom
  Connect »

Singleton Hospital

Swansea, United Kingdom
  Connect »